FDA Approves MYCOPHENOLATE MOFETIL — Ascend Laboratories, LLC

Ascend Laboratories, LLC has received FDA approval for the generic form of Mycophenolate Mofetil, a drug used to prevent organ rejection. This approval allows Ascend to enter competition against the market leader Myfortic, potentially driving competition and lowering costs for this essential transplant medication.